Advances in Glucocorticoid-Induced Osteoporosis
Open Access
- 2 March 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Rheumatology Reports
- Vol. 13 (3), 233-240
- https://doi.org/10.1007/s11926-011-0173-y
Abstract
Glucocorticoid-induced osteoporosis (GIOP) is one of the most important side effects of glucocorticoid use, as it leads to an increased risk of fractures. Recently, many published studies have focused on the cellular and molecular mechanisms of bone metabolism, the pathophysiology of GIOP, and the intervention options to prevent GIOP. In this review, recent advances in GIOP are summarized, particularly recent progress in our understanding of the mechanisms of GIOP resulting in improved insight that might result in the development of new treatment options in the near future.Keywords
This publication has 54 references indexed in Scilit:
- Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiationBMC Musculoskeletal Disorders, 2010
- Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The NetherlandsOsteoporosis International, 2010
- Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalkJournal of Bone and Mineral Research, 2010
- Intermittent Parathyroid Hormone Administration Counteracts the Adverse Effects of Glucocorticoids on Osteoblast and Osteocyte Viability, Bone Formation, and Strength in MiceEndocrinology, 2010
- Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)Calcified Tissue International, 2009
- Preferences of GPs and Patients for Preventive Osteoporosis Drug TreatmentPharmacoEconomics, 2009
- Glucocorticoid‐induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralizationArthritis & Rheumatism, 2008
- European guidance for the diagnosis and management of osteoporosis in postmenopausal womenOsteoporosis International, 2008
- Glucocorticoids suppress bone formation via the osteoclastJCI Insight, 2006
- Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblastsBiochemical and Biophysical Research Communications, 2005